Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of Leuco methylthioninium bis(hydromethanesulfonate) in Subjects with Mild to Moderate Alzheimer's Disease (2013–2017)

Grant type:
Worldwide Clinical Trials Pty Limited
Researchers:
Funded by:
Worldwide Clinical Trials Pty Limited